| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 29 | +82.76% | -4.08% | -0.53% | -3.55% | -5.11% | — |
| 14d | 29 | +58.62% | -3.74% | +1.35% | -5.09% | -0.57% | — |
| 30d | 29 | +62.07% | -5.56% | +1.97% | -7.53% | -7.80% | — |
| 60d | 29 | +51.72% | +0.14% | +3.23% | -3.08% | -4.87% | — |
| 90d | 29 | +72.41% | -10.07% | +3.18% | -13.25% | -30.46% | — |
| 180d | 29 | +79.31% | -23.02% | +5.48% | -28.49% | -40.93% | — |
| 1y | 29(5 pending) | +70.83% | +37.16% | +19.81% | +17.35% | -65.35% | — |
| 2y | 29(16 pending) | +53.85% | -7.94% | +38.47% | -46.41% | -74.68% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 21,217 | $33.47 | $710.1K | 212,204 | Jul 29, 2026 | Jul 29, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,667 | — | — | 233,421 | Jul 28, 2026 | Jul 29, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 13,900 | $33.38 | $464.0K | 201,671 | Jan 5, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 31,961 | $32.30 | $1.03M | 215,571 | Jan 5, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,500 | $32.09 | $48.1K | 189,891 | Jan 5, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,300 | $34.24 | $352.6K | 191,371 | Jan 5, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 91,000 | — | — | 91,000 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 41,000 | — | — | 215,483 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 32,049 | — | — | 247,532 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 6,185 | $35.00 | $216.5K | 173,592 | Oct 28, 2025 | Oct 28, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 11,117 | — | — | 179,777 | Oct 27, 2025 | Oct 28, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 4,266 | $27.76 | $118.4K | 168,660 | Jul 3, 2025 | Jul 3, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 7,667 | — | — | 172,926 | Jul 2, 2025 | Jul 3, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 4,700 | $43.32 | $203.6K | 165,259 | Jan 6, 2025 | Jan 6, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 45,609 | $42.69 | $1.95M | 169,959 | Jan 6, 2025 | Jan 6, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 21,667 | — | — | 215,568 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 44,533 | — | — | 193,901 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 37,200 | — | — | 37,200 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,967 | $80.65 | $642.5K | 150,572 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 12,750 | $7.77 | $99.1K | 199,802 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 9,265 | $76.94 | $712.8K | 203,496 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 4,251 | $4.68 | $19.9K | 204,053 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,206 | $81.44 | $98.2K | 149,366 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 23,082 | $77.68 | $1.79M | 180,414 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 49,672 | $74.56 | $3.70M | 231,381 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 4,251 | — | — | 0 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 18,620 | $75.79 | $1.41M | 212,761 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 51,000 | $8.52 | $434.5K | 281,053 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 26,000 | — | — | 0 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 51,000 | — | — | 153,000 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 15,825 | $78.69 | $1.25M | 164,589 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 26,000 | $5.80 | $150.8K | 230,053 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 6,050 | $79.78 | $482.7K | 158,539 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 12,750 | — | — | 0 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 2,974 | $57.71 | $171.6K | 187,552 | Jul 30, 2024 | Jul 31, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 500 | $58.71 | $29.4K | 187,052 | Jul 30, 2024 | Jul 31, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 12,662 | $56.96 | $721.2K | 190,526 | Jul 30, 2024 | Jul 31, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 21,667 | — | — | 203,188 | Jul 29, 2024 | Jul 31, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,667 | — | — | 181,521 | Jul 29, 2024 | Jul 31, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 3,101 | $73.49 | $227.9K | 238,509 | May 3, 2024 | May 3, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 30,000 | $4.88 | $146.4K | 241,610 | May 3, 2024 | May 3, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 30,000 | — | — | 60,000 | May 3, 2024 | May 3, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 4,249 | $4.68 | $19.9K | 211,610 | May 3, 2024 | May 3, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 847 | $76.07 | $64.4K | 174,854 | May 3, 2024 | May 3, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 4,249 | — | — | 4,251 | May 3, 2024 | May 3, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 45,570 | $74.44 | $3.39M | 192,939 | May 3, 2024 | May 3, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 17,238 | $75.49 | $1.30M | 175,701 | May 3, 2024 | May 3, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,667 | — | — | 223,971 | Mar 27, 2024 | Mar 27, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 16,610 | $83.34 | $1.38M | 207,361 | Mar 27, 2024 | Mar 27, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,667 | — | — | 212,397 | Mar 1, 2024 | Mar 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 20,093 | $85.22 | $1.71M | 192,304 | Mar 1, 2024 | Mar 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 15,000 | $17.90 | $268.5K | 180,730 | Jan 4, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 13,872 | $18.58 | $257.7K | 195,730 | Jan 4, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 28,334 | — | — | 188,724 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,000 | — | — | 240,491 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 155,000 | — | — | 155,000 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 18,233 | $17.40 | $317.3K | 170,491 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 30,889 | $17.40 | $537.5K | 209,602 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,500 | — | — | 0 | Apr 17, 2023 | Apr 18, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,500 | $20.00 | $150.0K | 149,279 | Apr 17, 2023 | Apr 18, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 7,500 | $13.07 | $98.0K | 156,779 | Apr 17, 2023 | Apr 18, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 4,097 | $7.77 | $31.8K | 190,823 | Apr 12, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 41,544 | $18.00 | $747.8K | 149,279 | Apr 12, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 4,097 | — | — | 12,750 | Apr 12, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 37,447 | — | — | 26,000 | Apr 12, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 37,447 | $5.80 | $217.2K | 186,726 | Apr 12, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 3,242 | $7.77 | $25.2K | 152,521 | Apr 11, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 14,553 | — | — | 63,447 | Apr 11, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 30,000 | — | — | 90,000 | Apr 11, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 14,553 | $5.80 | $84.4K | 205,574 | Apr 11, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 3,242 | — | — | 16,847 | Apr 11, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 30,000 | $4.88 | $146.4K | 191,021 | Apr 11, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 56,295 | $18.00 | $1.01M | 149,279 | Apr 11, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 8,500 | — | — | 8,500 | Apr 11, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 8,500 | $4.68 | $39.8K | 161,021 | Apr 11, 2023 | Apr 13, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 56,667 | — | — | 204,445 | Apr 3, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 30,911 | $7.77 | $240.2K | 178,689 | Apr 3, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 30,911 | $18.00 | $556.4K | 147,778 | Apr 3, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 30,911 | — | — | 0 | Apr 3, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 55,166 | $17.57 | $969.3K | 149,279 | Apr 3, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 32,000 | — | — | 0 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 12,250 | — | — | 0 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 12,250 | $4.65 | $57.0K | 271,307 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 32,000 | $8.52 | $272.6K | 217,057 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 42,000 | $7.69 | $323.0K | 259,057 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 131,029 | $17.00 | $2.23M | 147,778 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,500 | — | — | 0 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 7,500 | $4.12 | $30.9K | 278,807 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 42,000 | — | — | 0 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 20,708 | $8.42 | $174.4K | 185,057 | Jan 4, 2023 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 23,933 | $8.52 | $203.9K | 205,765 | Jan 3, 2023 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 204,000 | — | — | 204,000 | Jan 3, 2023 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 90,667 | — | — | 229,698 | Jan 3, 2023 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,233 | — | — | 158,728 | Dec 30, 2022 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 19,697 | $9.40 | $185.2K | 139,031 | Dec 30, 2022 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 8,835 | $4.62 | $40.8K | 136,304 | Jan 4, 2022 | Jan 5, 2022 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 53,333 | — | — | 145,139 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 3,097 | $4.88 | $15.1K | 91,806 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,667 | — | — | 96,791 | Sep 28, 2021 | Sep 30, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 2,306 | $6.50 | $15.0K | 94,485 | Sep 28, 2021 | Sep 30, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 808 | $6.68 | $5.4K | 89,751 | Jan 19, 2021 | Jan 19, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,783 | — | — | 93,346 | Jan 4, 2021 | Jan 6, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 78,000 | — | — | 78,000 | Jan 4, 2021 | Jan 6, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 64,667 | — | — | 86,563 | Jan 4, 2021 | Jan 6, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Financial Officer | 2,787 | $5.80 | $16.2K | 90,559 | Jan 4, 2021 | Jan 6, 2021 ↗ | View → |